DeCode Genetics Buy Adds to Amgen's Genomics Arsenal

What began as discussions around a scientific collaboration a few months ago blossomed into a full acquisition deal between Amgen Inc., of Thousand Oaks, Calif., and DeCode Genetics, of Reykjavik, Iceland, according to Terry McGuire, of Polaris Venture Partners, which helped form DeCode in the 1990s, and in 2010 purchased it out of bankruptcy with Arch Ventures.